Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of COVID-19 on Emergency Department Visits for Suicidal Ideation and Suicide Attempts among South Carolina Youth.

Southern medical journal·2025
Same author

Mental health criminal defenses in persons with neuropsychiatric disorders.

Behavioral sciences & the law·2023
Same author

Knowledge and Attitudes of Psychiatrists About the Gun Rights of Persons With Mental Illness.

The journal of the American Academy of Psychiatry and the Law·2020
Same author

Malpractice Law and Psychiatry: An Overview.

Focus (American Psychiatric Publishing)·2020
Same author

New aspects of iron-copper crosstalk uncovered by transcriptomic characterization of Col-0 and the copper uptake mutant spl7 in Arabidopsis thaliana.

Metallomics : integrated biometal science·2018
Same author

Genome-Wide Association Study Reveals Novel Genomic Regions Associated with 10 Grain Minerals in Synthetic Hexaploid Wheat.

International journal of molecular sciences·2018

Related Experiment Video

Updated: Jun 20, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Clozapine-induced bowel infarction: a case report.

Nicholas D McKinnon1, Alvi Azad, Brian M Waters

  • 1US Air Force (Wilford Hall Medical Center, Lackland AFB, Texas) and the University of Texas Health Science Center at San Antonio, Texas, USA. nicholas.mckinnon@lackland.af.mil

Psychiatry (Edgmont (Pa. : Township))
|September 3, 2009
PubMed
Summary

Clozapine effectively treats resistant schizophrenia but carries risks. This case highlights severe gastrointestinal issues, including bowel infarctions, necessitating surgery despite clozapine

Keywords:
atypical antipsychoticbowel surgeryclozapineconstipationischemic colitisschizoaffective disorder

Related Experiment Videos

Last Updated: Jun 20, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Area of Science:

  • Psychiatry and Pharmacology

Background:

  • Resistant schizophrenia often requires clozapine when standard antipsychotics fail or cause side effects.
  • Clozapine is a secondary treatment option due to serious potential side effects like agranulocytosis, requiring constant blood monitoring.

Observation:

  • A 40-year-old female patient experienced chronic constipation and bowel infarctions.
  • These severe gastrointestinal complications arose after long-term clozapine treatment.

Findings:

  • The patient underwent multiple abdominal surgeries, including subtotal colonic resections, due to clozapine-induced complications.
  • Despite the severe side effects and surgical interventions, clozapine remained the only effective treatment for her schizophrenic symptoms after other medications failed.

Implications:

  • This case underscores the critical balance between clozapine's efficacy in treatment-resistant schizophrenia and its significant gastrointestinal risks.
  • Highlights the need for vigilant monitoring of gastrointestinal health in patients on long-term clozapine therapy.
  • Emphasizes the challenges in managing patients who require clozapine despite its adverse effects.